←Back to Expert Scholars
Translational Medicine / 转化医学Squamous NSCLC Advances
Suresh Ramalingam
MD
🏢Emory University🌐USA
Executive Director, Winship Cancer Institute
85
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Suresh Ramalingam directs Winship Cancer Institute and is a leader in NSCLC clinical trials. He has conducted major squamous NSCLC studies with chemotherapy-immunotherapy combinations. His research informs cooperative group treatment pathways for advanced squamous lung cancer.
Share:
🧪Research Fields 研究领域
Squamous NSCLC
Immunotherapy
FLAURA trial
Targeted therapy
Cooperative group trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Suresh Ramalingam 的研究动态
Follow Suresh Ramalingam's research updates
留下邮箱，当我们发布与 Suresh Ramalingam（Emory University）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment